Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer
非小细胞肺癌患者接受纳武利尤单抗联合伊匹木单抗治疗后发生严重免疫相关性肺炎的危险因素
期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15385
Sumi, Toshiyuki; Sekikawa, Motoki; Koshino, Yuta; Nagayama, Daiki; Nagahisa, Yuta; Matsuura, Keigo; Shijubou, Naoki; Kamada, Koki; Suzuki, Keito; Ikeda, Takumi; Michimata, Haruhiko; Watanabe, Hiroki; Yamada, Yuichi; Osuda, Koichi; Tanaka, Yusuke; Chiba, Hirofumi